{"source": "EMA documents JSON (filtered)", "days": 3, "cutoff_utc": "2025-12-19T06:33:11.555137+00:00", "count": 79, "debug_skipped_str": 0, "debug_skipped_other": 0, "items": [{"id": "57312", "name": "Pirfenidone Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-17T17:03:00Z", "last_update_date": "2025-12-19T18:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pirfenidone-viatris-epar-product-information_en.pdf"}, {"id": "63476", "name": "Pirfenidone Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-04T14:00:00Z", "last_update_date": "2025-12-19T12:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pirfenidone-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "64073", "name": "Altuvoct : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-12T11:11:01Z", "last_update_date": "2025-12-19T10:39:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/altuvoct-epar-product-information_en.pdf"}, {"id": "66065", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-11T10:45:05Z", "last_update_date": "2025-12-19T08:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71854", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:22:53Z", "last_update_date": "2025-12-19T08:22:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71855", "name": "Altuvoct-PSUSA-00011062-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:23:31Z", "last_update_date": "2025-12-19T08:23:31Z", "reference_number": "EMADOC-1700519818-2767181", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/altuvoct-psusa-00011062-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "71856", "name": "Macitentan Accord : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:38:28Z", "last_update_date": "2025-12-19T08:38:28Z", "reference_number": "EMA/251911/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accord-epar-medicine-overview_en.pdf"}, {"id": "71857", "name": "Macitentan Accord : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:39:28Z", "last_update_date": "2025-12-19T08:39:28Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accord-epar-risk-management-plan_en.pdf"}, {"id": "71858", "name": "Macitentan Accord : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:40:31Z", "last_update_date": "2025-12-19T08:40:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accord-epar-product-information_en.pdf"}, {"id": "71859", "name": "Macitentan Accord : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:41:26Z", "last_update_date": "2025-12-19T08:41:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accord-epar-all-authorised-presentations_en.pdf"}, {"id": "71860", "name": "Macitentan Accord : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T08:42:29Z", "last_update_date": "2025-12-19T08:42:29Z", "reference_number": "EMA/CHMP/216790/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accord-epar-public-assessment-report_en.pdf"}, {"id": "56060", "name": "Vyvgart : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-12T10:34:00Z", "last_update_date": "2025-12-19T12:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/vyvgart-epar-product-information_en.pdf"}, {"id": "71862", "name": "Varicella vaccine (live) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:06:11Z", "last_update_date": "2025-12-19T09:06:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00010473-202503_en.pdf"}, {"id": "71861", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:04:47Z", "last_update_date": "2025-12-19T09:04:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf"}, {"id": "71863", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:12:47Z", "last_update_date": "2025-12-19T09:12:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf-0"}, {"id": "47660", "name": "Ruconest : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-05-18T09:20:00Z", "last_update_date": "2025-12-19T13:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ruconest-epar-risk-management-plan_en.pdf"}, {"id": "31810", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-19T12:49:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71864", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:24:35Z", "last_update_date": "2025-12-19T09:24:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "69781", "name": "Comirnaty : 3.2.P drug product", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-20T10:25:15Z", "last_update_date": "2025-12-19T11:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32p-drug-product_en.zip"}, {"id": "71721", "name": "Questions and answers on the refusal of the marketing authorisation for Hetlioz X-39", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-19T11:30:00Z", "reference_number": "EMEA/H/C/003870/X/0039", "url": "https://www.ema.europa.eu/en/documents/smop/questions-answers-refusal-marketing-authorisation-hetlioz-x-39_en.pdf"}, {"id": "69922", "name": "Comirnaty : 3.2.S Drug substance", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T09:31:43Z", "last_update_date": "2025-12-19T11:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32s-drug-substance_en.zip"}, {"id": "71866", "name": "Methylthioninium chloride Proveblue : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:32:51Z", "last_update_date": "2025-12-19T11:32:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/methylthioninium-chloride-proveblue-epar-risk-management-plan_en.pdf"}, {"id": "20098", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2012-02-28T01:00:00Z", "last_update_date": "2025-12-19T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71867", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:36:13Z", "last_update_date": "2025-12-19T11:36:13Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16662", "name": "Methylthioninium chloride Proveblue : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-06-06T02:00:00Z", "last_update_date": "2025-12-19T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/methylthioninium-chloride-proveblue-epar-product-information_en.pdf"}, {"id": "26375", "name": "Simulect : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:51:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/simulect-epar-product-information_en.pdf"}, {"id": "35844", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71868", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:03:14Z", "last_update_date": "2025-12-19T12:03:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "25860", "name": "Yargesa : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-04-10T18:57:00Z", "last_update_date": "2025-12-19T09:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/yargesa-epar-product-information_en.pdf"}, {"id": "68766", "name": "Yargesa : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-16T12:12:21Z", "last_update_date": "2025-12-19T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "35861", "name": "Leflunomide medac : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2010-08-05T02:00:00Z", "last_update_date": "2025-12-19T13:43:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-medac-epar-product-information_en.pdf"}, {"id": "69102", "name": "Leflunomide medac : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-04T11:58:20Z", "last_update_date": "2025-12-19T12:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-medac-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68206", "name": "Tuzulby : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:49:55Z", "last_update_date": "2025-12-19T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tuzulby-epar-product-information_en.pdf"}, {"id": "70993", "name": "Tuzulby : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-04T11:11:00Z", "last_update_date": "2025-12-19T12:17:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tuzulby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "27102", "name": "Pregabalin Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-31T02:00:00Z", "last_update_date": "2025-12-19T12:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pregabalin-viatris-epar-product-information_en.pdf"}, {"id": "63218", "name": "Pregabalin Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-16T11:00:00Z", "last_update_date": "2025-12-19T08:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pregabalin-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "19027", "name": "Replagal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-11-03T01:00:00Z", "last_update_date": "2025-12-19T11:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/replagal-epar-product-information_en.pdf"}, {"id": "70140", "name": "Replagal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-18T11:54:07Z", "last_update_date": "2025-12-19T12:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/replagal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "69347", "name": "Shingrix : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T12:36:03Z", "last_update_date": "2025-12-19T13:50:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/shingrix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "48900", "name": "Shingrix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-09-28T14:21:00Z", "last_update_date": "2025-12-19T11:47:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/shingrix-epar-risk-management-plan_en.pdf"}, {"id": "71869", "name": "Shingrix-X-0000243671 : EPAR - Assessment report - Extension", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T12:41:11Z", "last_update_date": "2025-12-19T12:41:11Z", "reference_number": "EMADOC-1700519818-2471078", "url": "https://www.ema.europa.eu/en/documents/variation-report/shingrix-x-0000243671-epar-assessment-report-extension_en.pdf"}, {"id": "52379", "name": "Minjuvi : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-09-08T15:00:00Z", "last_update_date": "2025-12-19T10:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/minjuvi-epar-product-information_en.pdf"}, {"id": "70461", "name": "Minjuvi : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-06T17:18:59Z", "last_update_date": "2025-12-19T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/minjuvi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16444", "name": "Olumiant : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-03-16T01:00:00Z", "last_update_date": "2025-12-19T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/olumiant-epar-product-information_en.pdf"}, {"id": "71870", "name": "Olumiant : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:53:04Z", "last_update_date": "2025-12-19T12:53:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/olumiant-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf-0"}, {"id": "71871", "name": "Metoprolol : List of nationally authorised medicinal products - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:47:09Z", "last_update_date": "2025-12-19T12:47:09Z", "reference_number": "EMADOC-1700519818-2771118", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-list-nationally-authorised-medicinal-products-psusa-00002039-202503_en.pdf"}, {"id": "71872", "name": "Metoprolol : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:49:53Z", "last_update_date": "2025-12-19T12:49:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002039-202503_en.pdf"}, {"id": "71875", "name": "Macitentan AccordPharma : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:08:09Z", "last_update_date": "2025-12-19T13:08:09Z", "reference_number": "EMA/251923/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accordpharma-epar-medicine-overview_en.pdf"}, {"id": "71876", "name": "Macitentan AccordPharma : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:09:15Z", "last_update_date": "2025-12-19T13:09:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accordpharma-epar-risk-management-plan_en.pdf"}, {"id": "71877", "name": "Macitentan AccordPharma : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:11:10Z", "last_update_date": "2025-12-19T13:11:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accordpharma-epar-product-information_en.pdf"}, {"id": "71878", "name": "Macitentan AccordPharma : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:12:19Z", "last_update_date": "2025-12-19T13:12:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accordpharma-epar-all-authorised-presentations_en.pdf"}, {"id": "71879", "name": "Macitentan AccordPharma : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T13:13:14Z", "last_update_date": "2025-12-19T13:13:14Z", "reference_number": "EMA/CHMP/216792/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accordpharma-epar-public-assessment-report_en.pdf"}, {"id": "60975", "name": "Product information URLs for member states", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-09-27T11:05:53Z", "last_update_date": "2025-12-19T13:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/product-information-urls-member-states_en.xls"}, {"id": "68207", "name": "Tuzulby : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:52:13Z", "last_update_date": "2025-12-19T13:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tuzulby-epar-all-authorised-presentations_en.pdf"}, {"id": "45256", "name": "Rotarix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-08-14T14:58:00Z", "last_update_date": "2025-12-19T15:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rotarix-epar-risk-management-plan_en.pdf"}, {"id": "71880", "name": "Rifampicin : List of nationally authorised medicinal products - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:27:19Z", "last_update_date": "2025-12-19T13:27:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-list-nationally-authorised-medicinal-products-psusa-00002640-202503_en.pdf"}, {"id": "71881", "name": "Rifampicin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:32:53Z", "last_update_date": "2025-12-19T13:32:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002640-202503_en.pdf"}, {"id": "71882", "name": "Olumiant : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:16Z", "last_update_date": "2025-12-19T14:48:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olumiant-epar-product-information-tracked-changes_en.docx"}, {"id": "71883", "name": "Rocuronium : List of nationally authorised medicinal products - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:22Z", "last_update_date": "2025-12-19T14:48:22Z", "reference_number": "EMADOC-1700519818-2775133", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-list-nationally-authorised-medicinal-products-psusa-00002656-202502_en.pdf"}, {"id": "71884", "name": "Rocuronium : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:50:51Z", "last_update_date": "2025-12-19T14:50:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002656-202502_en.pdf"}, {"id": "11519", "name": "Tremfya : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T11:59:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/overview/tremfya-epar-medicine-overview_en.pdf"}, {"id": "49890", "name": "Tremfya : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-01-22T10:29:00Z", "last_update_date": "2025-12-19T11:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/tremfya-epar-risk-management-plan_en.pdf"}, {"id": "17468", "name": "Tremfya : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T16:31:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tremfya-epar-product-information_en.pdf"}, {"id": "41843", "name": "Tremfya : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tremfya-epar-all-authorised-presentations_en.pdf"}, {"id": "69993", "name": "Tremfya : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-08T13:53:43Z", "last_update_date": "2025-12-19T16:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tremfya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71885", "name": "Tremfya-X-0000248626 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T15:07:42Z", "last_update_date": "2025-12-19T15:07:42Z", "reference_number": "EMADOC-1700519818-2583818", "url": "https://www.ema.europa.eu/en/documents/variation-report/tremfya-x-0000248626-epar-assessment-report-variation_en.pdf"}, {"id": "71886", "name": "Tremfya : EPAR - Statement indicating compliance with the agreed completed paediatric investigation plan", "type": "pip-compliance", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:12:46Z", "last_update_date": "2025-12-19T15:12:46Z", "reference_number": "EMADOC-1700519818-2494684", "url": "https://www.ema.europa.eu/en/documents/pip-compliance/tremfya-epar-statement-indicating-compliance-agreed-completed-paediatric-investigation-plan_en.pdf"}, {"id": "71887", "name": "Selegiline : List of nationally authorised medicinal products - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:18:31Z", "last_update_date": "2025-12-19T15:18:31Z", "reference_number": "EMADOC-1700519818-2775121", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-list-nationally-authorised-medicinal-products-psusa-00002688-202503_en.pdf"}, {"id": "71888", "name": "Selegiline : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:20:02Z", "last_update_date": "2025-12-19T15:20:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002688-202503_en.pdf"}, {"id": "69897", "name": "Attrogy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-28T16:29:07Z", "last_update_date": "2025-12-19T15:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/attrogy-epar-product-information_en.pdf"}, {"id": "71889", "name": "Attrogy : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:28:27Z", "last_update_date": "2025-12-19T15:28:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/attrogy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "55558", "name": "Technology Capability Investment Plan to 2028 - Becoming a digital hub for the European medicines regulator network", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T10:45:00Z", "last_update_date": "2025-12-19T10:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/technology-capability-investment-plan-2028-becoming-digital-hub-european-medicines-regulator-network_en.pdf"}, {"id": "63601", "name": "Fabhalta : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-14T11:11:01Z", "last_update_date": "2025-12-19T13:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/fabhalta-epar-product-information_en.pdf"}, {"id": "66907", "name": "Fabhalta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-20T16:24:17Z", "last_update_date": "2025-12-19T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/fabhalta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36422", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T15:08:00Z", "last_update_date": "2025-12-19T17:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "5223", "name": "Avastin : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T02:00:00Z", "last_update_date": "2025-12-19T12:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf"}, {"id": "66920", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-24T10:35:59Z", "last_update_date": "2025-12-19T12:03:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71891", "name": "Avastin-PSUSA-00000403-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T16:39:48Z", "last_update_date": "2025-12-19T16:39:48Z", "reference_number": "EMADOC-1700519818-2470418", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/avastin-psusa-00000403-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "67978", "name": "Avastin : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T12:05:23Z", "last_update_date": "2025-12-19T16:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avastin-epar-product-information-tracked-changes_en.docx"}]}